Breaking: Bill Gates Says It's "Worth 10 Microsofts"
Incredibly, this company is still a minnow in the ocean...With a market cap less than 1/1,000th that of Microsoft. It's your chance to join the big boys before AI gets absolutely massive. Get your hands on the AI Wonder Stock that could make you super-rich (plus a whole lot more)...
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
Moderna misses Q4 EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake challenges.
Major Michigan insurer in talks to settle lawsuits over fired workers and COVID-19 vaccine
DETROIT (AP) — A major Michigan insurance company is in talks to possibly settle more than 100 lawsuits by employees who were fired after declining to get a court records show.
270X More Lucrative Than Nvidia??? - Ad
If you've missed out on NVIDIA's recent 1,600% run...Don't worry. Because there's one AI stock that could be a lot more lucrative. It's currently trading for only $20. And it pays out 270X more in "AI Royalties" than NVIDIA.
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
Guardant Health beat Q4 estimates with a smaller EPS loss and strong revenue growth. Analysts raised price targets, citing momentum and solid financials.
Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst
Insulet's Q4 sales grew 17.2% to $597.5 million, exceeding forecasts. Omnipod revenue surged, and 2025 guidance projects up to 20% growth.
Discover the $20 Stock Fueling the AI Boom - Ad
If you are looking for the perfect retirement stock...Your search is over. AMD, NVIDIA, META... none of these companies could exist without this firm. And it could be yours for only about $20 a share.
Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million
FibroGen sells its China unit to AstraZeneca for $160 million, extending its cash runway into 2027 and advancing its CD46-targeting ADC and PET imaging agent.
New York sues vape distributors over Elf Bar and other fruit and candy e-cigarettes
New York on Thursday sued some of the country’s biggest distributors of , accusing the companies of violating state laws that prohibit the sale of vaping flavors and designs that appeal to children.
Crazy Opportunity: Tiny AI Stock You Need to see - Ad
I'll bet not one in 1 in 100,000 investors knows about this scorching opportunity! A tiny AI Wonder Stock could jumpstart the kind of carefree life you can only dream about right now. Getting positioned is easy...But you'll need to know its name and ticker symbol. (Which I'm prepared to give you now.)
Beauty market shifts to target the young at heart in a rapidly aging Japan
TOKYO (AP) — Yoshiko Abe is about to turn 89, but that hasn't stopped her from going to the gym every day and trying the free-of-charge makeup course at her housing complex.
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage recommendations on Feb. 26.
Some Traders Using AI to Pocket $1,100 per Day? - Ad
A shocking video leak has revealed a groundbreaking new AI trading system...It's reportedly helping some traders pocket over $1,100 a day -- using it for just 60 seconds! Here's the kicker: This system was developed to analyze market data and pinpoint high-probability trades nearly on autopilot.
Cats in Oregon euthanized after eating raw pet food tainted with bird flu
At least in Oregon were euthanized this month after eating raw pet food , prompting agriculture officials to issue a public health alert Friday about the products.
Quaker Oats recalls 10,000 boxes of Pearl Milling Company pancake mix for milk allergy risk
The Quaker Oats Co. 10,000 boxes of pancake mix because it contains milk not declared on the label and could pose a risk of potentially dangerous allergic reactions.
"Boring Trade" Generates $185 Every Day. Like Clockwork. - Ad
Forget cryptos, pot stocks, and other "shiny object" investments. Instead, you could collect an average of $185 every day of the year with this "boring" trade strategy Forbes magazine says is "like finding money in the street."
UNC and Duke Health will build North Carolina's first standalone children's hospital
RALEIGH, N.C. (AP) — Two North Carolina-based university health systems plan to construct the state's first standalone children's hospital — an undertaking that its boosters said will change lives physically and economically for decades to come.
AbbVie Builds Momentum With Immunology Growth, Goldman Remains Positive
AbbVie plans to release Q4 2024 results on Jan. 31. Analysts predict $14.8 billion in sales, $2.10 EPS. Immunology growth remains a key focus for investors.
Elon's Social Security Shock? - Ad
New research reveals what Elon Musk could be planning in Washington D.C. and how it may impact your money. In short, Elon has much bigger plans than simply "draining the swamp." His next big project could bring about nothing short of a revolution in our economy... It could change the way you file and pay your taxes... collect Social Security... and how you travel. To do it, Elon will likely use the same strategy he's applied in every other business.
Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars
Novo Nordisk's amycretin trial results highlight significant weight loss in adults with obesity, with further clinical development planned.
Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York Attorney General Letitia James announced Thursday.
Shocking Elon Move: Bigger Than DOGE? - Ad
After blowing everyone's mind with his recent DOGE moves, what Elon Musk is about to do next will not only shock the world... But it could also put an extra $30,000 a year in your pocket.
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and $9 price target.
BrightSpring Health Divests Community Living Business For $850 Million To Focus On Core Activities
BrightSpring will sell its Community Living business to Sevita for $835M in a deal set to close in 2025, boosting operational focus and revenue growth projections.
This Is the "New" Gold -- "MIT Miracle Metal" - Ad
MIT scientists just developed a brand-new metal... A metal that's shaping up to be, not only the biggest breakthrough in artificial intelligence... but in human technology. It's so valuable that some are referring to it as the "new gold".
Donald Trump has sweeping plans for a second administration. Here's what he's proposed
WASHINGTON (AP) — has promised sweeping actions in his second administration.
Ozempic, Wegovy and other drugs are among 15 selected for Medicare's price negotiations
WASHINGTON (AP) — Popular weight loss drugs like have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday.
Claim Your Share of $5.39 Billion in AI Equity Checks - Ad
Virtually every AI model is built off stolen data...so it's only fair that you deserve some kind of compensation...And the U.S. government seems to agree. Which is why you could now receive as much as $3,452.50 per month on average from "AI Equity Checks."
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
FDA denies Vanda's Tradipitant application for gastroparesis, urging new trials for efficacy and safety. Vanda disputes the agency's review process.
UnitedHealth Q4 Earnings: Revenue Falls Short, Medical Ratio Rises To 85.5%, Stock Falls
UnitedHealth Group posted mixed Q4 results, with EPS beating estimates and revenue falling short. The company reaffirmed its 2025 guidance.
5 Top "America First" Stocks for Trump's First 100 Days - Ad
Tim Bohen says these 5 tiny "America First" stocks are next up in 2025. Thanks to Elon Musk and Donald Trump's new alliance... They could be off to the races in Trump's first 100 days. Right now for a limited time...He's giving away the names and ticker symbols for only $1.00!
What products contain Red 3 dye? Checking ingredient labels is the best way to find out
The Food and Drug Administration is ordering food and drug makers to called Red 3 from the products U.S. consumers eat and drink.
FDA floats plan to make cigarettes nonaddictive, but its fate rests with Trump
WASHINGTON (AP) — Federal officials on Wednesday released a far-reaching proposal to by capping their , a goal long sought by antismoking advocates that is unlikely to go into effect anytime soon.
The 2 Best Stocks to Play Trump's "Stargate" - Ad
The first is a little-known company that already got a takeover offer from Nvidia. The second is a firm that's trading at just $20 a share and has an 8% yield.
Interpol cracks down on illegal mining in West Africa as police make 200 arrests
PARIS (AP) — Interpol said Tuesday a major operation targeting in West Africa has resulted in 200 arrests and the seizure of harmful chemicals, explosives and drugs.
Elon Musk says a third patient got a Neuralink brain implant. The work is part of a booming field
Elon Musk said a third person has from his brain-computer interface , one of many groups
Nvidia Is About to Shock the World: March 17th - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: March 17th! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Is Elon Musk's Mental Health a Cause for Concern? Biographer Thinks So
Biographer Seth Abramson, who says he is writing a biography of Elon Musk, has expressed concerns over the mental health of the billionaire entrepreneur.
Why Is Neuromuscular-Focused Dyne Therapeutics Stock Trading Lower On Friday?
Dyne Therapeutics' DYNE-101 shows promising Phase 1/2 results for myotonic dystrophy type 1, with plans for Accelerated Approval by 2026.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.